MAUDE Adverse Event Report: ABBOTT GMBH ALINITY C TOTAL BILIRUBIN REAGENT KIT; DIAZO COLORIMETRY, BILIRUBIN

Model Number	04V5121
Medical Device Problem Code	High Test Results (2457)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	06/15/2023
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A final report will be submitted when the evaluation is complete.Completed information for section a1 patient identification: sids (b)(6).All available patient information was included.Additional patient details are not available.
Event or Problem Description
The customer observed falsely elevated alinity c total bilirubin results for multiple patients.On 23jun2023, the following data was provided: sample id (b)(6) initial result = 3.8, repeat = 0.6; sample id (b)(6) initial result = 3.4, repeat = 0.4; sample id (b)(6) initial result = 4.4, repeat = 0.2; sample id (b)(6) initial result = 3.7, repeat = 0.3; sample id (b)(6) initial result = 2.9, repeat = 0.4; sample id (b)(6) initial result = 4.1, repeat = 0.6; sample id (b)(6) initial result = 5.1, repeat = 0.7; sample id (b)(6) initial result = 4.9, repeat = 0.5; sample id (b)(6) initial result = 2.6, repeat = 0.2; sample id (b)(6) initial result = 8.9, repeat = 1.7; sample id (b)(6) initial result = 2.9, repeat = 0.2; sample id (b)(6) initial result = 6.0, repeat = 1.0; sample id (b)(6) initial result = 3.3, repeat = 0.4; sample id (b)(6) initial result = 4.1, repeat = 0.3; sample id (b)(6) initial result = 9.8, repeat = 1.6; sample id (b)(6) initial result = 2.9, repeat = 0.5; sample id (b)(6) initial result = 4.8, repeat = 0.5; sample id (b)(6) initial result = 4.8, repeat = 1.0; sample id (b)(6) initial result = 1.7, repeat = 0.5; sample id (b)(6) initial result = 7.1, repeat = 1.2; sample id (b)(6) initial result = 3.6, repeat = 0.4; sample id (b)(6) initial result = 5.2, repeat =1.1; sample id (b)(6) initial result = 3.9, repeat = 0.3; sample id (b)(6) initial result = 5.8, repeat = 0.8; sample id (b)(6) initial result = 8.6, repeat = 1.7; sample id (b)(6) initial result = 4.3, repeat = 0.4; sample id (b)(6) initial result = 6.9, repeat = 1.1; sample id (b)(6) initial result = 5.3, repeat = 0.9; sample id (b)(6) initial result = 2.8, repeat = 0.3; sample id (b)(6) initial result = 4.0, repeat = 0.5; sample id (b)(6) initial result = 2.6, repeat = 0.4; sample id (b)(6) initial result = 3.4, repeat = 0.5; sample id (b)(6) initial result = 4.3, repeat = 0.7; sample id (b)(6) initial result = 6.3, repeat = 1.0; sample id (b)(6) initial result = 2.6, repeat = 0.4; sample id (b)(6) initial result = 4.0, repeat = 0.3; sample id (b)(6) initial result = 2.9, repeat = 0.4; sample id (b)(6) initial result = 4.1, repeat = 0.4; sample id (b)(6) initial result = 5.2, repeat = 0.6; sample id (b)(6) initial result = 3.6, repeat = 0.7; sample id (b)(6) initial result = 4.5, repeat = 0.4; sample id (b)(6) initial result = 4.1, repeat = 0.4; sample id (b)(6) initial result = 3.3, repeat = 0.5; sample id (b)(6) initial result = 4.0, repeat = 0.6; sample id (b)(6) initial result = 4.7, repeat = 0.8; sample id (b)(6) initial result = 4.2, repeat = 0.5.No impact to patient management was reported.
Event or Problem Description
The customer observed falsely elevated alinity c total bilirubin results for multiple patients.On (b)(6( 2023, the following data was provided: sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id(b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) sample id (b)(6) no impact to patient management was reported.
Additional Manufacturer Narrative
Update: d4 - lot # updated from blank to 63736uq02 an evaluation is in process.A final report will be submitted when the evaluation is complete.Section d4 - catalog # changed from 04v51-21 to 04v51-31.
Event or Problem Description
The customer observed falsely elevated alinity c total bilirubin results for multiple patients.On 23jun2023, the following data was provided: sample id (b)(6) initial result = 3.8, repeat = 0.6.Sample id (b)(6) initial result = 3.4, repeat = 0.4.Sample id (b)(6) initial result = 4.4, repeat = 0.2.Sample id (b)(6) initial result = 3.7, repeat = 0.3.Sample id (b)(6) initial result = 2.9, repeat = 0.4.Sample id (b)(6) initial result = 4.1, repeat = 0.6.Sample id (b)(6) initial result = 5.1, repeat = 0.7.Sample id (b)(6) initial result = 4.9, repeat = 0.5.Sample id (b)(6) initial result = 2.6, repeat = 0.2.Sample id (b)(6) initial result = 8.9, repeat = 1.7.Sample id (b)(6) initial result = 2.9, repeat = 0.2.Sample id (b)(6) initial result = 6.0, repeat = 1.0.Sample id (b)(6) initial result = 3.3, repeat = 0.4.Sample id (b)(6) initial result = 4.1, repeat = 0.3.Sample id (b)(6) initial result = 9.8, repeat = 1.6.Sample id (b)(6) initial result = 2.9, repeat = 0.5.Sample id (b)(6) initial result = 4.8, repeat = 0.5 sample id (b)(6) initial result = 4.8, repeat = 1.0.Sample id (b)(6) initial result = 1.7, repeat = 0.5.Sample id (b)(6) initial result = 7.1, repeat = 1.2.Sample id (b)(6) initial result = 3.6, repeat = 0.4.Sample id (b)(6) initial result = 5.2, repeat =1.1.Sample id (b)(6) initial result = 3.9, repeat = 0.3.Sample id (b)(6) initial result = 5.8, repeat = 0.8.Sample id (b)(6) initial result = 8.6, repeat = 1.7.Sample id (b)(6) initial result = 4.3, repeat = 0.4.Sample id (b)(6) initial result = 6.9, repeat = 1.1.Sample id (b)(6) initial result = 5.3, repeat = 0.9.Sample id (b)(6) initial result = 2.8, repeat = 0.3.Sample id (b)(6) initial result = 4.0, repeat = 0.5.Sample id (b)(6) initial result = 2.6, repeat = 0.4.Sample id (b)(6) initial result = 3.4, repeat = 0.5.Sample id (b)(6) initial result = 4.3, repeat = 0.7.Sample id (b)(6) initial result = 6.3, repeat = 1.0.Sample id (b)(6) initial result = 2.6, repeat = 0.4.Sample id (b)(6) initial result = 4.0, repeat = 0.3.Sample id (b)(6) initial result = 2.9, repeat = 0.4.Sample id (b)(6) initial result = 4.1, repeat = 0.4.Sample id (b)(6) initial result = 5.2, repeat = 0.6.Sample id (b)(6) initial result = 3.6, repeat = 0.7.Sample id (b)(6) initial result = 4.5, repeat = 0.4.Sample id (b)(6) initial result = 4.1, repeat = 0.4.Sample id (b)(6) initial result = 3.3, repeat = 0.5.Sample id (b)(6) initial result = 4.0, repeat = 0.6.Sample id (b)(6) initial result = 4.7, repeat = 0.8.Sample id (b)(6) initial result = 4.2, repeat = 0.5.No impact to patient management was reported.
Additional Manufacturer Narrative
Update: additional information d4 - expiration date update from blank to 7/31/2024, h4 - device mfg date updated from blank to 4/18/2023.The complaint investigation for falsely elevated alinity c total bilirubin results included a review of data and information provided by the customer, search for similar complaints, ticket trending review, device history record review, and labeling review.Return testing was not completed as returns were not available.Ticket and trending review did not identify trends for the complaint issue.Device history record review did not identify any non-conformances or deviations with the likely cause list number and complaint issue.Labeling was reviewed and found to sufficiently address the customer¿s issue.Based on the investigation, no systemic issue or deficiency with the alinity c total bilirubin reagent lot 63736uq02 was identified.

• Brand Name: ALINITY C TOTAL BILIRUBIN REAGENT KIT
• Common Device Name: DIAZO COLORIMETRY, BILIRUBIN
• Manufacturer (Section D): ABBOTT GMBH; max-planck-ring 2; wiesbaden 65205 ; GM 65205
• Manufacturer (Section G): ABBOTT GMBH; max-planck-ring 2; wiesbaden 65205 ; GM 65205
• Manufacturer Contact: siobhan wright ; lisnamuck; post market surveillance; longford N39 E-932 ; EI N39 E932 ; 433331157
• MDR Report Key: 17307457
• Report Number: 3002809144-2023-00305
• Device Sequence Number: 7261345
• Product Code: CIG
• UDI-Device Identifier: 00380740158415
• UDI-Public: 00380740158415
• Combination Product (Y/N): N
• Initial Reporter State: FL
• Initial Reporter Country: US
• PMA/510(K) Number: K121985
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 08/22/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 07/31/2024
• Device Model Number: 04V5121
• Device Catalogue Number: 04V51-31
• Device Lot Number: 63736UQ02
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Follow-Up
• Initial Date Received by Manufacturer: 06/23/2023
• Supplement Date Received by Manufacturer: 07/18/2023; 08/18/2023
• Initial Report FDA Received Date: 07/12/2023
• Supplement Report FDA Received Date: 08/06/2023; 08/22/2023
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 04/18/2023
• Is the Device Labeled for Single Use? (Y/N): No
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: ALNTY C PROCESSING MODU, 03R67-01, (B)(6).; ALNTY C PROCESSING MODU, 03R67-01, (B)(6).; ALNTY C PROCESSING MODU, 03R67-01, (B)(6).
• Patient Sex: Unknown